advisorsecurities master

CNTBConnect Biopharma Holdings Limited Ordinary Shares

CSNasdaq (XNAS)·USD

Identity

Security key
13585
Ticker
CNTB
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2025-09-03
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
CNTB

Detail

Enriched 2026-08-14 20:47

Market cap
$146,705,777.49
Shares outstanding (class)
62,963,853
Shares outstanding (weighted)
62,963,853
SIC
2834 PHARMACEUTICAL PREPARATIONS
Employees
64
Location
SAN DIEGO, CA
Description

Connect Biopharma Holdings Ltd is a clinical-stage biopharmaceutical company dedicated to transforming care for asthma and chronic obstructive pulmonary disease (COPD). The company is advancing rademikibart, a next-generation antibody designed to target interleukin-4-receptor alpha. It is currently conducting clinical studies of rademikibart for the treatment of acute exacerbations of asthma and COPD. The company operates in one operating segment: treatment of respiratory diseases.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data